Modalis Therapeutics Corporation (4883), listed on the Tokyo Stock Exchange Growth market, said on Nov. 18 that EVO FUND exercised its remaining 19th series moving-strike warrants between Nov. 2 and Nov. 18, 2026, with 4.38 million new shares delivered in November and no warrants left outstanding.
The 19th series warrants were issued on June 12, 2026 through a third-party allotment to EVO FUND, with 240,000 units issued in total. The 43,800 units exercised in November represent 18.3% of the total and equal the entire balance unexercised at the end of October.
All November exercises took place on three days at an exercise price of ¥28.0:
| Date | New shares | Units exercised |
|---|---|---|
| Nov. 10 | 100,000 | 1,000 |
| Nov. 13 | 1,700,000 | 17,000 |
| Nov. 18 | 2,580,000 | 25,800 |
All shares delivered were newly issued; no treasury shares were used. The daily exercise price, adjusted under the moving-strike clause, ranged between ¥28.0 and ¥30.0 during the period.
Shares outstanding at the end of October stood at 115,954,098, including 64 treasury shares. Under Article 434 of the TSE listing regulations, the 4.38 million shares delivered amount to 4.5% of the 96,334,098 shares listed as of the warrants' payment date.
The company referred investors to its May 27, 2026 announcement on the issuance of the 19th series warrants and its 2nd series unsecured private-placement bonds for further details.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。